Jul 27, 2016 - Teva Pharmaceuticals is rapidly expanding on multiple fronts.Huge inroads are in progress to the 115+ billion dollar sales per year Japanese pharmaceutical markets.Latest update on huge 40.5 billion d
Jul 21, 2016 - Teva Pharmaceutical Industries (TEVA) prices a €4B offering of senior notes. The three tranches are: €1.75B of 0.375% fixed rate senior notes due 2020: 99.
Jul 19, 2016 - Teva Pharmaceutical (TEVA) has successfully priced a debt offering for $15M worth of senior notes, maturing between 2018 and 2046, to help fund its acquisi
Jul 14, 2016 - Allergan's sale of its generic business to Teva is proceeding.Closing the Teva transaction should be a major catalyst for Allergan shares.Capital allocation plan balances M&A flexibility, debt pay dow
Jul 14, 2016 - Companies In The News are:
Jul 14, 2016 - Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.
Jul 14, 2016 - Teva Pharmaceutical (TEVA) will raise between $20B-$25B next week to finance its acquisition of Allergan's (AGN) generics business, Globes reports. The bon
Jul 13, 2016 - View slideshowTeva Pharmaceutical Industries Limited (NYSE:TEVA) 2016-2019 Preliminary Financial Outlook Conference July 13, 2016, 08:00 AM ET Executives Kevin C. Mannix - Senior Vice President of Inv
Jul 13, 2016 - On Wednesday, shares of Allergan (AGN) and Teva Pharmaceuticals (TEVA) are both on the rise, up around 2% and 3%, respectively, in morning trading after Teva CEO Erez Vigodman said it expects its $40.5 billion acquisition of Allergan's generics business to close any day.
Jul 13, 2016 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2016 Q2 earnings call.